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January 2009278 Letters to the Editortients (N  684 patients). When compared with all patients (N 
75 studies), high-risk patients had lower odds ratio (EVAR/OSR)
of cardiac, pulmonary, and renal problems. Lower rates of type I
endoleak or conversion were also observed in high-risk patients.3
Other results indicated that EVAR outcomes had improved over
time as previously reported by Frank et al.4
We continue collecting data on these high-risk patients to
evaluate the midterm outcomes associated with EVAR and OSR,
which will confirm if EVAR is cost-effective in high-risk patients
based on longer-term data.
Jean-Eric Tarride, PhD
Gord Blackhouse, BComm, MBA, MSc
Guy De Rose, BSc, MD, FRCSC
Teresa Novick, RN, BA
James M. Bowen, BSc Phm, MSc
Robert Hopkins, BA, BSc, MA
Daria O’Reilly, PhD
Ron Goeree, MA
McMaster University
St Joseph’s Healthcare Hamilton
Hamilton, Ontario, Canada
University of Western Ontario
London Health Sciences Center (LHSC)
London, Ontario, Canada
REFERENCES
1. Tarride JE, Blackhouse G, De Rose G, Novick T, Bowen JM,Hopkins R,
et al. Cost-effectiveness analysis of elective endovascular repair compared
with open surgical repair of abdominal aortic aneurysms for patients at a
high surgical risk: a 1-year patient-level analysis conducted in Ontario,
Canada. J Vasc Surg 2008. [Epub ahead of print]
2. Blackhouse G, Hopkins R, Bowen J, De Rose G, Novick T, Tarride JE,
et al. A cost-effectiveness model comparing endovascular repair to open
surgical repair of abdominal aortic aneurysms in Canada. Value inHealth,
2008. [Epub ahead of print]
3. Hopkins R, Bowen J, Campbell K, De Rose G, Novick T, O’Reilly D,
et al. Effects of study design and trends for EVAR versus OSR. Vascular
Health and Risk Management, 2008. [Epub ahead of print]
4. Franks SC, Sutton AJ, Bown MJ, Sayers RD. Systematic review and
meta-analysis of 12 years of endovascular abdominal aortic aneurysm
repair. Eur J Vasc Endovasc Surg 2007;33:154-71.
doi:10.1016/j.jvs.2008.08.094
Regarding “Symptomatic acute occlusion of the
internal carotid artery: Reappraisal of urgent vascular
reconstruction based on current stroke imaging”
Weis-Müller et al reported a single-center experience with
surgical revascularization of acute extracranial internal carotid ar-
tery (ICA) occlusion in the acute stage.1 In the Discussion section,
they cited our previous article2 and stated “Nowadays interven-
tional teams are also dealing with acute ICA occlusion. The largest
series was actually presented by a Taiwanese group, who treated 30
patients with acute cervical ICA occlusion by using endovascular
techniques.” After comparing with our results, they concluded
that it is better to treat cervical ICA occlusion surgically. We think
that there are a number of issues that need to be clarified.
Firstly, our series included endovascular recanalization at-
tempts only in patients with either recurrent neurologic deficit or
objective ipsilateral hemisphere ischemia after ICA occlusion doc-
umentation. Mean duration from occlusion documentation to the
procedure was 179  254 days (ranging from 56 to 1309 days).2
Therefore, the ICA occlusions were “chronic”, instead of “acute”
in our report.
Secondly, as the authors mentioned, the success of surgery in
acute carotid occlusion depends on the duration of the occlusion.Their success rate in recanalizing ICA occlusion was 86% in pa-
tients with occlusion duration less than 72 hours. In contrast, Paty
et al3 reported a low success rate of only 34% in 90 ICA occlusions
within 14 days from symptom onset. Therefore, the role of surgery
for ICA occlusion should be limited in the very acute stage. Our
report, on the other hand, demonstrated an acceptable success rate
of 73% in endovascular recanalization for chronic ICA occlusion, in
which setting surgery has been proven ineffective.4 With the ad-
vance of device and skill, endovascular recanalization for ICA
occlusion, in both acute and chronic stage, may become the
treatment of choice in the future.
Irrespective of these issues, Weis-Müller et al are to be ac-
knowledged for applying diffusion/perfusion mismatch in select-
ing patients who may potentially benefit from urgent revascular-
ization. We believe that using imaging modalities to identify
viability/ischemia is crucial in clinical judgment for patients with
ICA occlusion, in both acute1 and chronic2 stages, and further
studies are mandatory to prove this concept.
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Reply
We thank Dr Kao very much for his interesting comment.
Indeed, his series of 30 chronic carotid occlusions reopened by
endovascular technique1 cannot be compared with our series of 35
acute carotid occlusions reopened surgically.2 After reading his
article, we misinterpreted his series of carotid occlusions “acute”
because time interval elapsed after carotid occlusion was not de-
fined precisely. In the section “patient selection,” he wrote: “the
most recent cerebral infarction, if documented, should be at least 2
weeks before intervention.” We concluded that his strategy is to
wait 2 weeks after symptomatic carotid occlusion before starting
with his intervention. Now we understand that his indication for
intervention is different from ours. His intention is to treat recur-
rent neurological symptoms caused by chronic carotid occlusion.
On the contrary, we want to reopen acutely occluded carotid
arteries to safe brain from enlarging infarction and to prevent
neurologic disturbances caused by carotid occlusion. Until re-
cently, it was not generally accepted that reopening a chronically
occluded internal carotid artery (ICA) is a safe way of enhancing
cerebral perfusion, but his results show that endovascular tech-
nique may change the dogma. However, our approach is designed
to take care for the acute stroke patient as early as possible after
acute ICA occlusion in order to prevent the patient from chronic
occlusion and further sequelae.
JOURNAL OF VASCULAR SURGERY
Volume 49, Number 1 Letters to the Editor 279Barbara T. Weis-Müller, MD
Wilhelm Sandmann, MD
Department of Vascular Surgery and Kidney Transplantation
University Clinic of Düsseldorf
Düsseldorf, Germany
REFERENCES
1. Kao HL, Lin MS, Wang CS, Lin YH, Lin LC, Chao CL, et al. Feasibility
of endovascular recanalization for symptomatic cervical internal carotid
artery occlusion. J Am Coll Cardiol 2007;49:765-71.
2. Weis-Müller BT, Huber R, Spivak-Dats A, Turowski B, Siebler M,
SandmannW. Symptomatic acute occlusion of the internal carotid artery:
reappraisal of urgent vascular reconstruction based on current stroke
imaging. J Vasc Surg 2008;47:752-759; discussion 759.
doi:10.1016/j.jvs.2008.08.099
Regarding “Long-term results of stent graft
treatment of subclavian artery injuries: Management
of choice for stable patients?”
We read with interest the article regarding stent graft treat-
ment of 57 traumatic sublcavian arterial injuries.1 It is surprising
that no mention was made of the vertebral artery. Certainly with
stent grafts varying from 30 to 60 mm in length, the vertebral
artery was covered in many (if not most) of their cases. If this is
true, did they first determine if the contralateral vertebral artery
was patent all the way to the basilar artery? After all, a hypoplastic
vertebral artery is an uncommon, but real, entity. The authors
reported that they treated 39% of their subclavian injuries with
stent grafts and believe that up to 50% of such injuries could be
treated in this fashion. Does proximity of the subclavian injury to
the vertebral artery origin play a role in the 50% who cannot be
treated endovascularly?
Also of interest is the statement that a stent graft cannot be
used if there is much of a difference in arterial diameters at the
proximal and distal landing zones. Except for their 12 cases of
arteriovenous fistulae, the diameter of a subclavian artery should
not change much from proximal to distal. Even if it did, Fluency
stent grafts (Bard, Tempe, Arizona) have been shown to have
minimal infolding when oversized up to 3 mm relative to the
vessel. How often would proximal to distal subclavian diameter
ever be a problem?
Overall, we found this series of 57 subclavian arterial injuries
treated endovascularly without limb loss or other incapacitating
symptoms to be impressive. However, we would like to have seen
a discussion of the vertebral artery and believe that proximal and
distal luminal discrepancy of the subclavian artery would be a rare
contraindication to stent graft placement.
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We appreciate the interest of Drs Smith and Carlson in our
article reporting the long-term results of stent graft treatment of
subclavian artery injuries.1 We thank them for the 2 interesting
comments. We did not describe all the technical details of the
procedure but did refer to our previously published article2 where
the issue of the vertebral artery was discussed. We did cover the
vertebral artery in many of the cases after confirming by angiogra-
phy that a patent normal sized contra lateral vertebral artery with
good cross flow into the Circle of Willis was present. No neuro-
logical complications were encountered as a result of this approach.
Although the reported incidence of congenital atresia or hypopla-
sia of one vertebral artery is 2%-3%,3 we did not exclude any patient
from endovascular treatment on the basis of this finding. We agree
that it might be a rare contraindication to stent graft treatment if
encountered on the contra lateral side to the injury.
We agree that luminal discrepancy is a rare contraindication to
stent graft treatment. However, 2 of the 4 patients that were
excluded from endovascular treatment on the basis of radiological
findings had a difference between proximal and distal arterial
diameters of more than 5 mm. They both presented with a chronic
arteriovenous fistula, respectively 7 and 10 years after injury, with
massively dilated proximal and small atrophic distal arteries. This
discrepancy was regarded as incompatible with successful endovas-
cular treatment and we were forced to treat them with open
surgery.
We thank Drs Smith and Carlson for focusing the attention on
these 2 issues.
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Regarding “Reference value of transcutaneous oxygen
measurement in diabetic patients compared with
nondiabetic patients”
We read with great interest the article of deMeijer et al1 about
the values of transcutaneous oxygen pressure (TcPO2) measure-
ments in diabetic compared with nondiabetic patients. The authors
found a 6-mm Hg difference in the mean chest and main foot
TcPO2 values between diabetic and nondiabetic subjects with
apparently no peripheral arterial disease. The authors suggest in
their conclusion that resting TcPO2 could be proposed as an
additional tool in the diagnostic armamentarium of vascular sur-
geons to assess peripheral vascular disease in diabetic patients.
First, there might be a lot of reasons (skin thickness, use of
vasoactive drugs) other than vascular disease that could modify
TcPO values. It is also not unlikely that the difference observed2
resulted from vascular dysfunction rather than from vascular dis-
